Clinical trials
PET clinical trials
Below are recruiting pet clinical trials, each written for real people, not researchers. We’re tracking 576 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07357727RecruitingPhase 3
Study of Pelabresib and Ruxolitinib for Myelofibrosis
This trial tests a combination of two drugs (pelabresib and ruxolitinib) for people with myelofibrosis whose spleen is enlarged and who have bothersome symptoms. It aims to see if adding pelabresib to standard care helps control the disease better.
Denver, ColoradoAges 18 years+ - NCT07169630RecruitingPhase 1
PET scan study for Alzheimer's or mild cognitive impairment
This study uses a special PET scan to look at a brain protein called PDE4 in people with Alzheimer's disease or mild cognitive impairment. It may help researchers understand how this protein is involved in memory and thinking problems.
Bethesda, MarylandAges 50–100 - NCT07099053Recruiting
Brain scan study for aging adults in Baltimore
This study uses a special brain scan (amyloid PET) to look at brain changes in healthy older adults. It may help researchers learn more about aging and memory loss.
Baltimore, MarylandAges 55–110 - NCT03019757Recruiting
Testing ways to tell dementia causes apart
This study looks at how to distinguish Alzheimer’s disease, Lewy body dementia, and Parkinson’s disease when someone has memory and thinking problems. It may help doctors choose the most accurate diagnosis and treatment path for the right condition.
Columbus, OhioAges 18 years+ - NCT03966443Recruiting
Fluciclovine PET/CT scan for people with multiple myeloma
This trial studies how a special PET/CT scan (using fluciclovine) may help doctors evaluate multiple myeloma. You might be eligible if you’re a candidate for stem cell transplant (ASCT).
OsloAges 18 years+ - NCT04072653Recruiting
Sentinel node biopsy versus watchful waiting after PET
This trial studies whether taking a sample from the sentinel lymph node (a first lymph node that can be involved) improves care compared with observation, after a breast cancer PET scan of the armpit area. It may help people with certain early breast cancers avoid unnecessary procedures if the lymph nodes look negative on scans.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT03716401Recruiting
Imaging tests to predict kidney disease in type 2 diabetes
This study uses special kidney imaging to look for patterns that can predict how diabetic kidney disease may progress. It may help researchers find better ways to identify people at higher risk using noninvasive (and possibly biopsy-related) tests.
TurkuAges 18–80 - NCT05172310RecruitingPhase 1
PET scan study using a new tracer for solid tumors
This trial tests a special PET/CT scan using a new tracer (68Ga-FAPI) to help show tumors in the pancreas, bile ducts, stomach, or certain ovarian cancers. It may help doctors better see where cancer is in preparation for surgery or biopsy.
StockholmAges 19 years+ - NCT04065321Recruiting
Blood test for tumor cells in certain early breast cancers
This trial looks at a blood test that may detect “circulating tumor cells” (cancer cells that can travel in the bloodstream) in people with a specific type of breast cancer. It may help doctors better track the disease and guide treatment for people whose tumors have certain hormone and growth-factor features.
Shenyang, LiaoningAges 18–60 - NCT05741151Recruiting
Testing a nerve target in Parkinson’s disease
This trial is studying the “superior cervical ganglion” as a possible treatment approach for Parkinson’s disease. It may help people whose symptoms are truly caused by Parkinson’s, not by another condition.
RomeAges 30–80 - NCT04737317Recruiting
Check criteria to diagnose cardiac sarcoidosis
This study tests how doctors can best tell whether someone has cardiac sarcoidosis, a condition where inflammation affects the heart. It may help you get a more accurate diagnosis using expert guidelines and special heart tests, and it groups patients as proven, probable, or unlikely.
LeipzigAges 18 years+ - NCT04832620Recruiting
Using MRI-guided planning to improve proton radiation for rare bone tumors
This trial is testing a better way to plan proton radiation using MRI images, aiming to deliver treatment more accurately for chordoma or chondrosarcoma in the spine/sacrum area. You may benefit if the trial’s planning method helps target the tumor while sparing nearby healthy tissue.
Delft, South HollandAges 50 years+ - NCT04571086Recruiting
FAPI-PET scan to help find and stage tumors
This study uses a special PET scan (FAPI-PET) during routine workup to help detect tumors and decide how far they may have spread. You may be able to take part if you need a staging or restaging scan and can safely complete the imaging.
Essen, North Rhine-WestphaliaAges 18 years+ - NCT05681858Recruiting
Testing heart inflammation and reduced blood flow in MINOCA
This study looks at why some people have chest pain and heart injury signs, but their heart arteries are not blocked. It tests scans of blood flow and heart tissue to better understand the cause and guide care.
BergenAges 18 years+ - NCT06189898Recruiting
Using scans to find radiation-sensitive esophageal cancer
This study tests whether a special imaging scan (functional imaging) can identify which esophageal cancers respond best to radiation. If you have stage II–IVA esophageal cancer and meet the health criteria, joining may help personalize your treatment.
BerlinAges 18 years+ - NCT04235114RecruitingPhase 1/Phase 2
PET scan test for EGFR-positive cancers using an antibody tracer
This study tests a special PET scan agent (an antibody tracer) to help doctors see EGFR-positive cancers without needing invasive procedures. It is mainly for early testing (Phase 1/2) to understand how well it works for imaging.
Saskatoon, SaskatchewanAges 18–80 - NCT06232889Recruiting
Imaging study to check liver tumor response to radiation treatment
This study uses special MRI scans and PET scans to see how liver tumors respond to a radiation treatment called radioembolization (SIRT). The goal is to improve how treatment response is measured in people with metastatic liver disease.
UtrechtAges 18 years+ - NCT04642027RecruitingPhase 3
PSMA scan-guided salvage radiation after prostate surgery
This trial tests whether using a specialized PSMA PET scan to guide radiation can better treat prostate cancer that returns after prostate surgery. It targets the “prostate bed” area with a shorter, stronger radiation schedule (hypofractionated) to control rising PSA levels.
Arnhem, GelderlandAges 18–80 - NCT06284070Recruiting
Comparing FDG and FAPI PET scans for cancer
This study compares two types of PET scans (FDG and FAPI) in people with suspected or newly diagnosed cancer. It aims to learn which scan gives better images of different cancers, potentially helping guide treatment decisions.
Chongqing, Chongqing MunicipalityAges 18 years+ - NCT02678884Recruiting
PET-CT scan study for head and neck cancer before radiotherapy
This study uses PET-CT scans (a type of imaging that highlights active cancer cells) in people with a specific kind of head and neck cancer. The goal is to see how well the first scan identifies tumors that should be checked again with a second scan, to better guide care with radiotherapy.
Toronto, OntarioAges 18 years+ - NCT06363396Recruiting
Brain scan study for fatigue after stem cell transplant
This study uses a special brain scan (PET) to look at why people feel very tired or have trouble thinking clearly after a stem cell transplant. It aims to better understand these problems to help future patients.
StockholmAges 20–75 - NCT06019130RecruitingPhase 2
Nivolumab for newly diagnosed nasopharyngeal cancer
This trial tests whether the immunotherapy drug nivolumab (Opdivo) can help treat nasopharyngeal cancer in both children and adults. It is for people who have just been diagnosed and have not yet received any cancer treatment.
AachenAges 3 years+ - NCT07830654RecruitingPhase 2
Pet scan for Parkinson's disease
This study tests a new PET scan tracer called [18F]AV-133 to see if it can track Parkinson's disease over time. The scan may help doctors better understand the disease, and you would be part of the PPMI research program.
New Haven, ConnecticutAges 18 years+ - NCT07825285Enrolling by invitation
Training positive emotions for teens with low mood
This study tests a simple training to help teenagers with mild to moderate depression focus on positive events and boost positive emotions. It's a short, supportive program that might help you feel better day by day.
LeuvenAges 12–16
Hear when a new PET trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pet?
- Yes. Clin2 currently lists 576 recruiting pet studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pet trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pet trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.